Aug. 25 at 1:22 AM
$MRNA I hate to be right, but the current price reflects a successful, market-ready product. In reality, this targets a narrow area of recurrent melanoma, requires Merck’s drug, and may suit only 6% of existing patients. People bought the news without properly understanding the science or mechanism.
Read, research, and avoid excessive leverage. Loud bulls and bears often act like sheep, following sentiment rather than science or valuation. Remember: “diamond hands” now work at McDonald’s.
Don’t blindly be bullish or bearish. Follow the 9, 20 and 50 MAs, trade the price, and take profits. Don’t wait for a magic number while leveraged. Set milestones and stick to them: take 25%, another 25%, then another, and let the rest ride. Keep any single stock to 5% of your money. If you have
$1,000, risk no more than
$50 and grind higher slowly. I started with a
$25K brokerage account; after six years, it’s near
$380K. About 30% came from allocating 10% to options on
$SNDK and
$ATAI and DFTX
